Updated Drug Labeling for Patient Safety Act

Cost and committee reports

Official records Congress.gov attaches to H.R. 4134.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. SCHIFF, as printed in the Congressional Record (Vol. 169, No. 104, June 14, 2023, Page H2934):
  Article V of the United States Constitution The single subject of this legislation is: Generic drug labeling
  Source: Congress.gov, Congressional Record June 14, 2023 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  108 characters

  Congress.gov bill record

  H.R. 4134, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hr/4134

  Record last updated by Congress.gov

  July 26, 2024

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  61053eb7bd7f6312161c3f1010077298c72685482f02520310eeff97552f668a

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of July 26, 2024). Not every bill gets one.

From the Congress.gov bill record for H.R. 4134, last updated July 26, 2024. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.